Comorbidity Between Mood Disorders and Chronic Somatic Diseases, With a Focus on Cardiometabolic Disease, and Its Mechanistic Crosstalk
Depression and Anxiety · 2026
DOI: 10.1155/da/7688691 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Depression and Anxiety, 2026. Verfasst von Hongzhen Du und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Special Education and Rehabilitation, Binzhou Medical University, Yantai 264003, Shandong, China, bzmc.edu.cn. Hauptthemen laut MEDLINE: Mood Disorders, Cardiovascular Diseases, Metabolic Syndrome, Metabolic Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 263 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
The comorbidity of mood disorders (MDs), represented by depression and anxiety, with chronic somatic diseases (CDs), particularly cardiometabolic conditions, poses a significant global public health challenge, markedly increasing the risk of adverse prognoses and all‐cause mortality. Epidemiological studies indicate that ~36% of patients with multimorbidity exhibit psychosomatic comorbidity, with higher risk populations concentrated among females, older adults, and socioeconomically disadvantaged individuals. This review systematically analyzes the epidemiological distribution patterns of MD–CD comorbidity, with the strongest emphasis on cardiometabolic diseases—diabetes, metabolic syndrome (MetS), obesity, hypertension (HTA), and cardiovascular disease (CVD)—for which the mechanistic data are most developed, while also addressing osteoarthritis, psoriasis, inflammatory bowel disease (IBD), cancer, and neurological disorders. By integrating molecular mechanisms with clinical evidence, we highlight core pathological pathways and critically evaluate the strength of evidence supporting each: hypothalamic–pituitary–adrenal (HPA) axis dysfunction and insulin resistance (IR), substantiated by clinical data and Mendelian randomization; NLRP3 inflammasome‐mediated neuroinflammation as a transdiagnostic inflammatory node; gut–brain axis dysregulation involving bile acid–GLP‐1 signaling and gut‐derived metabolites such as trimethylamine N‐oxide (TMAO); and the kynurenine pathway (KP) as a branched metabolite axis with organ‐specific consequences. Sex‐specific mechanisms, particularly estrogen‐regulated neuroendocrine and metabolic pathways, are identified as consistent biological modifiers of this comorbidity. A bidirectional vicious cycle underpins MD–CD comorbidity: metabolic abnormalities exacerbate limbic system dysfunction via HPA‐axis hyperactivity, neuroinflammatory cascades, and disrupted gut–brain signaling, while MDs aggravate metabolic dysregulation through neuroendocrine disturbances and reduced treatment adherence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Special Education and Rehabilitation, Binzhou Medical University, Yantai 264003, Shandong, China, bzmc.edu.cn.
- First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan 250355, Shandong, China, sdutcm.edu.cn.
- Department of Orthopedic Trauma, Binzhou Medical University Hospital, Binzhou 256603, Shandong, China, bzmc.edu.cn.
- Department of Rehabilitation Medicine, Yantaishan Hospital, Yantai 264001, Shandong, China, ytsyy.com.
- Department of Rehabilitation Medicine, Binzhou Medical University Hospital, Binzhou 256603, Shandong, China, bzmc.edu.cn.
- Medical Research Center, Binzhou Medical University Hospital, Binzhou 256603, Shandong, China, bzmc.edu.cn.
ORCID-Profile: Hongzhen Du, Gangqiang Du, Jilin Fan, Chen Li, Wei Li
Förderung
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Du, H., Du, G., Zhang, Q., Zhao, Y., Fan, J., Zhou, Y., Sun, Z., Li, C., & Li, W. (2026). Comorbidity Between Mood Disorders and Chronic Somatic Diseases, With a Focus on Cardiometabolic Disease, and Its Mechanistic Crosstalk. Depression and Anxiety. https://doi.org/10.1155/da/7688691
Vancouver
Du H, Du G, Zhang Q, Zhao Y, Fan J, Zhou Y, et al. Comorbidity Between Mood Disorders and Chronic Somatic Diseases, With a Focus on Cardiometabolic Disease, and Its Mechanistic Crosstalk. Depression and Anxiety. 2026. doi:10.1155/da/7688691
BibTeX
@article{Du2026,
author = {Du, Hongzhen and Du, Gangqiang and Zhang, Qian and Zhao, Yixuan and Fan, Jilin and Zhou, Yufeng and Sun, Zihao and Li, Chen and Li, Wei},
title = {Comorbidity Between Mood Disorders and Chronic Somatic Diseases, With a Focus on Cardiometabolic Disease, and Its Mechanistic Crosstalk},
journal = {Depression and Anxiety},
year = {2026},
doi = {10.1155/da/7688691}
}
EUVIMED